Review of the current published evidence for single-dose HPV vaccination
The primary objective of this review is to summarize and assess the current evidence that could support a change to a single-dose schedule of HPV vaccine. The review also aims to identify gaps that remain in determining whether a single dose could be sufficiently protective to have a major impact against HPV infection and its sequelae, within the context of immunization programs.
Visit the Single-Dose HPV Vaccine Evaluation Consortium page for additional resources.
Publication date: May 2022